TNF inhibition is being evaluated as a treatment strategy for patients with deficiency of adenosine deaminase 2, a genetic disease causing early-onset lacunar stroke.
Adenosine Deaminase 2 Deficiency and TNF Inhibition The manifestations of a deficiency of adenosine deaminase 2, a genetic disease, include early-onset lacunar stroke. In a series of 15 patients wi...
Ombrello et al. (Wed,) studied this question.